LLY

Lilly(Eli) & Co

Jun 18 • 03:46PM ET

1,098.48

-13.52 -1.22 %

Healthcare • Drug Manufacturers - General • USA • Mega • NYSE

Jun 16, 1:40 PMEli Lilly said Tuesday it will acquire non-opioid pain drug developer 4E Therapeutics, adding early-stage MNK inhibitor pain candidates to its pipeline.

Peers: NVO PFE MRK ABBV JNJ BMY AZN NVS AMGN SNY

| Held by: VTI VOO IVV SPY VUG XLV VIG IWF VHT SPYM

Scroll to Statements

Index	S&P 500	P/E	39.54	EPS (ttm)	27.78	Insider Own	10.05%	Shs Outstand	943.50M	Perf Week	-5.38%
Market Cap	1034.48B	Forward P/E	24.64	EPS next Y	44.59	Insider Trans	-0.34%	Shs Float	847.09M	Perf Month	7.55%
Enterprise Value	1072.57B	PEG	0.86	EPS next Q	8.81	Inst Own	74.78%	Short Float	1.16%	Perf Quarter	19.73%
Income	25.27B	P/S	14.32	EPS this Y	51.21%	Inst Trans	-0.41%	Short Ratio	3.09	Perf Half Y	4.19%
Sales	72.25B	P/B	33.22	EPS next Y	21.79%	ROA	24.54%	Short Interest	9.80M	Perf YTD	2.21%
Book/sh	33.07	P/C	195.85	EPS next 5Y	28.54%	ROE	107.64%	52W High	1182.73 -7.12%	Perf Year	39.93%
Cash/sh	5.61	P/FCF	87.50	EPS past 3/5Y	49.25% 27.59%	ROIC	35.82%	52W Low	623.78 76.10%	Perf 3Y	145.36%
Dividend Est.	6.97 (0.63%)	EV/EBITDA	29.62	Sales past 3/5Y	31.69% 21.58%	Gross Margin	82.83%	Volatility	2.76% 3.09%	Perf 5Y	402.62%
Dividend TTM	6.46 (0.59%)	EV/Sales	14.85	EPS Y/Y TTM	130.02%	Oper. Margin	47.30%	ATR (14)	34.58	Perf 10Y	1387.25%
Dividend Ex-Date	May 15, 2026	Quick Ratio	1.10	Sales Y/Y TTM	47.44%	Profit Margin	34.98%	RSI (14)	53.96	Recom	1.53
Dividend Gr. 3/5Y	15.24% 15.18%	Current Ratio	1.50	EPS Q/Q	169.45%	SMA20	-0.83%	Beta	0.52	Target Price	1258.33
Payout	26.14%	Debt/Eq	1.39	Sales Q/Q	55.55%	SMA50	8.64%	Rel Volume	0.80	Prev Close	1112.00
Employees	50000	LT Debt/Eq	1.26	Earnings	Apr 30 BMO	SMA200	13.70%	Avg Volume	3.17M	Price	1098.48
IPO	Jul 09, 1970	Option/Short	Yes / Yes	EPS/Sales Surpr.	22.64% 11.11%	Trades		Volume	2,446,247	Change	-1.22%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-17-26	Downgrade	HSBC Securities	Hold → Reduce	$850
Feb-25-26	Initiated	RBC Capital Mkts	Outperform	$1250
Feb-20-26	Initiated	Barclays	Overweight	$1350
Jan-07-26	Resumed	UBS	Buy	$1250
Dec-16-25	Upgrade	Daiwa Securities	Neutral → Buy	$1230
Dec-15-25	Reiterated	Goldman	Buy	$951 → $1145
Dec-15-25	Reiterated	BofA Securities	Buy	$1286 → $1268
Nov-13-25	Initiated	Scotiabank	Sector Outperform	$1165
Nov-10-25	Upgrade	Leerink Partners	Market Perform → Outperform	$1104
Oct-20-25	Reiterated	BMO Capital Markets	Outperform	$840 → $930
Oct-14-25	Upgrade	Erste Group	Hold → Buy
Sep-17-25	Downgrade	Berenberg	Buy → Hold	$830
Aug-27-25	Upgrade	HSBC Securities	Reduce → Hold	$700
Aug-18-25	Downgrade	Daiwa Securities	Outperform → Neutral	$700
Aug-07-25	Downgrade	Leerink Partners	Outperform → Market Perform	$715
Jun-05-25	Downgrade	Erste Group	Buy → Hold
Apr-28-25	Downgrade	HSBC Securities	Buy → Reduce	$1150 → $700
Apr-22-25	Initiated	Cantor Fitzgerald	Overweight	$975
Dec-10-24	Resumed	BofA Securities	Buy	$997
Nov-15-24	Initiated	Wolfe Research	Outperform	$1000

Show Previous Ratings

Today 01:00AM	This Investment Pro Is Leaning Into Risk. Why He Likes Defense, Ag Tech, and Infrastructure. (Barrons.com)
Jun-17-26 03:41PM	J&J Has No Plans to Enter Obesity Drugs Market, CEO Says (Bloomberg)
03:33PM	J&J Skips GLP-1 Race, Targets No. 1 Cancer Spot By 2030 (GuruFocus.com)
02:21PM	Eli Lilly Stock's Trillion-Dollar Question (Trefis)
01:08PM	The Number That Could Test Johnson & Johnson Stock (Trefis)
11:57AM	Loading…
11:57AM	Everyone Is Watching Eli Lilly Stock's New Drugs. Here Is the Metric That Vanished (Trefis)
11:36AM	Johnson & Johnson to stay out of obesity drugs, focus on cancer, CEO says (Investing.com)
09:15AM	Snubbing Nvidia for Adobe Costs Florida Stock-Picker $50 Billion (Bloomberg)
08:21AM	SpaceX's near $3 trillion rally comes with one big catch: Chart of the Day (Yahoo Finance)
08:00AM	Big pharma taps UK playbook to pressure Europe on drug prices (Reuters Videos)
Jun-16-26 02:52PM	Novo Nordisk to File Oral Wegovy in China (GuruFocus.com)
01:06PM	Eli Lilly Takes Another Stab at the Market for Painkillers. This Attempt Might Work. (Barrons.com)
08:37AM	Novo Seeks China Approval for Wegovy Pill (GuruFocus.com)
08:23AM	Lilly buys non-opioid pain drugmaker 4E (BioPharma Dive)
05:15AM	How Lilly is defending its GLP empire (Pharma Voice)
07:06AM	Loading…
Jun-15-26 07:06AM	Factbox-Global drugmakers rush to boost US presence as tariff threat looms (Reuters)
05:43AM	Lilly scores early positive data for new JAK drug (BioPharma Dive)
01:31AM	India's Electronics Mart eyes new markets as tech hubs fear job losses (Reuters)
Jun-14-26 04:00AM	Middle-aged adults taking GLP-1s for obesity can save over $192K on lifetime medical costs, higher if they dont have college degrees, new study finds (Fortune)
03:15AM	Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with previously treated CLL/SLL (PR Newswire)
Jun-13-26 11:15AM	Lilly to present initial clinical data for first-in-class type II JAK2 inhibitor in patients with previously treated myelofibrosis at the 2026 EHA Annual Meeting (PR Newswire)
Jun-12-26 04:53PM	What Could Push JNJ Stock Higher From Here? (Trefis)
03:14PM	JNJ Raised the Bar: So Why Is the Stock Standing Still? (Trefis)
01:31PM	The Catch Hiding In Eli Lilly Stock's Growth Story (Trefis)
01:07PM	Eli Lilly Stock Hits Buy Zone As Earnings Soar 156%. Funds Are Loading Up. (Investor's Business Daily)
07:55AM	Novo Nordisk comeback stirs as Wegovy pill wins UK approval (Pharmaceutical Technology)
06:23AM	Abridge partners with Eli Lilly, Nvidia as AI scribe eyes expansion (Healthcare Dive)
Jun-11-26 04:33PM	SpaceX is officially worth more than Tesla, Meta and Walmart (MarketWatch)
04:12PM	SpaceX prices historic IPO at $135/share in largest ever new listing (Investing.com)
02:39PM	Abridge wants to be the operating system for medicineand NVIDIA and Eli Lilly are helping build it (Fortune)
02:03PM	Loading…
02:03PM	Why Did Wall Street Misprice JNJ Stock? (Trefis)
12:22PM	Employers Rethink GLP-1 Coverage (GuruFocus.com)
Jun-10-26 09:30AM	Zepbound (tirzepatide) and Shaquille O'Neal launch national campaign after NBA legend learns the obstructive sleep apnea he has lived with for years is treatable (PR Newswire)
07:31AM	Eli Lilly continues dealmaking roll with $1bn AlzeCure agreement (Pharmaceutical Technology)
05:12AM	AstraZenecas extensive obesity drug push; $125M for ultrasound-aided genetic medicine (BioPharma Dive)
Jun-09-26 07:17PM	LLYs EBGLYSS Gets FDA Nod For Every-8-Weeks Dosing, Cutting Treatment To Six Injections Per Year (Stocktwits)
06:18PM	FDA approves Lilly's EBGLYSS (lebrikizumab-lbkz) for one maintenance dose every eight weeks in patients with moderate-to-severe atopic dermatitis (PR Newswire)
03:48PM	Novo Wegovy Pill Tops 3M Prescriptions (GuruFocus.com)
03:40PM	Dow Jones AI Giant Nvidia Stock Tumbles To Key Support Level Amid Market Sell-Off (Investor's Business Daily)
01:03PM	Lilly Makes a New Alzheimer's Pipeline Move (GuruFocus.com)
09:07AM	Pentagon Accuses Alibaba, Baidu of Aiding Chinas Military (Bloomberg)
07:50AM	Stealthy startup Treeline plans a reverse merger (BioPharma Dive)
07:42AM	Stocks rally as investors dive back into tech; oil slips (Reuters)
06:51AM	AI Bulls Are Back in the Driving Seat as Stock Market Sidelines Bubble Fears (Barrons.com)
04:00AM	Convatec and Lilly Foundation Commit $5m to Partners In Health to Improve Care for Non-communicable Disease and Chronic Conditions (Business Wire)
Jun-08-26 11:08PM	Why Did AAPL, OSCR, LLY Stocks Hit 52-Week Highs Today? (Stocktwits)
05:32PM	LLY Stock Climbs As Oral GLP-1 Pill Beats Novo Nordisk, AstraZenecas Therapies In Diabetes Trials (Stocktwits)
04:21PM	Big Pharma Stock Eli Lilly Concocts New Buy Zone (Investor's Business Daily)
04:09PM	Why Eli Lilly, In A Buy Zone, Is Still The 'Clear Winner' Of The 'Weight Loss Olympics' (Investor's Business Daily)
03:49PM	Why Is Lilly Stock Growing Like A Silicon Valley Tech Darling? (Trefis)
03:04PM	Eli Lilly's Weight-Loss Pill Clears Its Toughest Hormonal Test Yet (GuruFocus.com)
02:48PM	Lilly Rises on Retatrutide Data (GuruFocus.com)
02:30PM	Lilly's oral GLP-1 Foundayo (orforglipron) delivered superior A1C control and weight loss in three pivotal type 2 diabetes trials (PR Newswire)
01:26PM	Novo Drops 3.2% As CEO Eyes Longevity And Aesthetics (GuruFocus.com)
11:13AM	Campbell's Earnings Beat; Eli Lilly Obesity Drug Results \| Stock Movers (Bloomberg)
08:55AM	Is AbbVie Stock The Right Defensive Pick In This Volatile Market? (Trefis)
08:06AM	Eli Lilly Obesity Drug Shows Promise in Menopause (GuruFocus.com)
07:54AM	Eli Lilly stock jumps on retatrutide Phase 3 weight loss results (Quartz)
07:54AM	Eli Lilly stock surged after its next-generation weight loss drug posted record results (Quartz)
06:43AM	Eli Lilly shares climb after new obesity drug results impress at ADA conference (LLY) (InvestorsHub)
06:32AM	LLY Stock Heads To Record High Heres Why Retails Bullish On Latest GLP-1 Data (Stocktwits)
06:16AM	Eli Lilly stock jumps after late-stage trial of next-generation weight-loss drug (MarketWatch)
05:44AM	Eli Lilly, Novo Both Share Good News on Weight-Loss Drugs. Only One Stock Is Rising. (Barrons.com)
05:35AM	Eli Lilly Shares Rise Premarket on Late-Stage Weight Loss Trial Success (The Wall Street Journal)
05:04AM	Premarket movers: Chip stocks advance, Eli Lilly climbs after late-stage trial (MarketWatch)
04:58AM	Nasdaq, S&P 500, Dow Futures Mixed As Iran-Israel Escalation Lifts Oil Prices: Why NVDA, STI, MRVL, LLY, SOC Are In Focus (Stocktwits)
02:56AM	Stock Market Today: Dow, S&P 500 and Nasdaq to rise after worst day for stocks in ten months; Oil jumps as Iran hits Israel (MarketWatch)
12:08AM	Why Did Solidion, Eli Lilly, Citigroup Stocks Hit 52-Week Highs Last Week? (Stocktwits)
Jun-07-26 07:35PM	The Wegovy pill is still dominating the GLP-1 pill market (MarketWatch)
11:00AM	Lilly's Foundayo (orforglipron), the only oral GLP-1 taken without food or water restrictions, was associated with significant weight loss in women at every stage of menopause (PR Newswire)
Jun-06-26 03:45PM	Eli Lilly shares phase 3 data on triple agonist weight loss drug retatrutide (Investing.com)
02:53PM	Tired of nausea or taking a GLP-1 pill every day? These experimental drugs could be better than Zepbound and Wegovy. (MarketWatch)
02:30PM	Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity and its complications (PR Newswire)
10:04AM	Pfizer targets obesity market with monthly weight-loss injection data (Investing.com)
Jun-05-26 02:32PM	UnitedHealth, Eli Lilly Lead Healthcare Rebound as Investors Seek Stability (GuruFocus.com)
02:31PM	Novo And Lilly Push Beyond US As Only 1%-2% Use Obesity Drugs Globally (GuruFocus.com)
01:19PM	GLP-1 Sales Forecast Jumps To $150 Billion By 2030 (GuruFocus.com)
08:53AM	TD Cowen Raises GLP-1 Sales Forecast To $150B By 2030 Industry Leaders LLY, NVO To Remain Dominant (Stocktwits)
04:55AM	GSK, Takeda and others notch key clinical wins in tough-to-treat diseases (Pharma Voice)
03:29AM	HIMS Stock Slides Overnight: CEO Sees Healthcare Potential In Anthropic's AI Leap As Lilly, WeightWatchers Turn Up The Heat (Stocktwits)
Jun-04-26 08:08PM	Gilead, Merck, Eli Lilly Lead $106B Biopharma Takeover Wave In 2026 (Stocktwits)
05:08PM	Eli Lilly, IBD Stock Of The Day, Flashes Two Buy Signals (Investor's Business Daily)
04:23PM	75% Upside For LLY Stock? (Trefis)
10:05AM	Weight Watchers Expands Reach Through LillyDirect Partnership (WW) (InvestorsHub)
09:25AM	Eli Lilly Cuts Planned Germany Investment Amid Policy Concerns (GuruFocus.com)
06:44AM	Eli Lilly continues genetic medicine push with $1.9bn Ascidian partnership (Pharmaceutical Technology)
Jun-03-26 04:13PM	Lilly Strikes Up To $1.9 Billion Kidney Disease Gene Therapy Deal (GuruFocus.com)
10:02AM	Eli Lilly signs $1.9B gene-editing deal with Ascidian Therapeutics (Quartz)
09:19AM	Novo Nordisk is taking its new weight loss pill global (Quartz)
09:00AM	GeoVax CEO Highlights Renewed Strategic Interest in Vaccine Platforms and Infectious Disease Innovation (NewMediaWire)
09:00AM	Eli Lilly, Ascidian Sign $1.9 Billion Kidney-Disease Treatment Deal (The Wall Street Journal)
04:40AM	Why Is Novo Nordisk Stock Climbing Premarket Today? (Stocktwits)
03:30AM	Getting Alzheimer's Drugs Into the Brain Is Hard. Now There's a New Trick. (Barrons.com)
03:00AM	Lilly, Ascidian link up in RNA exon editing pact (BioPharma Dive)
Jun-02-26 08:44PM	ASCO26: Bispecific antibody and RET fusion-targeting assets garner attention in NSCLC (Pharmaceutical Technology)
09:30AM	Lilly to spotlight growing hematology portfolio at 2026 European Hematology Association (EHA) Annual Meeting (PR Newswire)
09:13AM	Beyond the AI Boom: 3 Forgotten Sectors to Buy Amid Historic Market Disconnect (Barrons.com)
12:01AM	M&A Is Back in a Big Way. These Are the Sectors in Play. (Barrons.com)
Jun-01-26 01:20PM	Lilly's Retevmo Cuts Lung Cancer Recurrence Risk in Phase 3 Trial (GuruFocus.com)
06:16AM	Lilly and Hanmi sign $1.26bn licensing deal for sonefpeglutide (Pharmaceutical Technology)

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Chairman & CEOMr. David A. Ricks

Executive VP & CFOMr. Lucas E. Montarce

Ph.D.Dr. Daniel M. Skovronsky M.D.

Executive VPMs. Anat Hakim J.D.

Executive VPMr. Jacob S. Van Naarden

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Yuffa Ilya	EVP&Pres, LLY USA&Global Capab	Jun 10 '26	Sale	1150.77	2,500	2,876,925	29,804	Jun 11 04:23 PM
Yuffa Ilya	Officer	Jun 10 '26	Proposed Sale	1150.77	2,500	2,876,925		Jun 10 11:03 AM
LILLY ENDOWMENT, INC.	Shareholder	May 28 '26	Proposed Sale	1082.92	310,000	335,705,200		May 28 03:02 PM
LILLY ENDOWMENT, INC.	Shareholder	May 22 '26	Proposed Sale	1041.65	300,000	312,495,000		May 22 02:05 PM
LILLY ENDOWMENT, INC.	Shareholder	May 20 '26	Proposed Sale	1021.41	305,000	311,530,050		May 20 04:22 PM
LILLY ENDOWMENT INC	Former 10% Shareholder	May 06 '26	Sale	995.36	15,828	15,754,537	91,881,150	May 07 04:00 PM
LILLY ENDOWMENT, INC.	Shareholder	May 06 '26	Proposed Sale	988.87	300,000	296,661,000		May 06 04:35 PM
Zakrowski Donald A	SVP, Finance, & CAO	Feb 16 '26	Option Exercise	0.00	184	0	3,607	Feb 18 04:22 PM
Montarce Lucas	EVP & CFO	Feb 16 '26	Option Exercise	0.00	368	0	16,418	Feb 18 04:21 PM
Custer Kenneth L.	EVP & President, Card Met Hlth	Feb 16 '26	Option Exercise	0.00	207	0	10,232	Feb 18 04:21 PM
Brown Adrienne S	EVP, President LLY Imm	Feb 16 '26	Option Exercise	0.00	391	0	5,312	Feb 18 04:19 PM
Yuffa Ilya	EVP&Pres, LLY USA&Global Capab	Feb 01 '26	Option Exercise	0.00	3,394	0	29,654	Feb 03 04:32 PM
Skovronsky Daniel	EVP, CS&PO & Pres. LRL	Feb 01 '26	Option Exercise	0.00	12,684	0	150,165	Feb 03 04:31 PM
Van Naarden Jacob	EVP,Pres LLY Oncology&HdCorpBD	Feb 01 '26	Option Exercise	0.00	4,108	0	24,670	Feb 03 04:31 PM
Ricks David A	President, Chair, and CEO	Feb 01 '26	Option Exercise	0.00	31,932	0	547,098	Feb 03 04:29 PM
Rau Diogo	EVP & CIDO	Feb 01 '26	Option Exercise	0.00	3,752	0	23,471	Feb 03 04:28 PM
Jonsson Patrik	EVP & President, LLY Int'l	Feb 01 '26	Option Exercise	0.00	3,930	0	57,581	Feb 03 04:27 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Feb 01 '26	Option Exercise	0.00	3,572	0	43,303	Feb 03 04:26 PM
Hakim Anat	EVP, GC & Secretary	Feb 01 '26	Option Exercise	0.00	6,700	0	17,662	Feb 03 04:25 PM
Dozier Eric	EVP, Chief People Officer	Feb 01 '26	Option Exercise	0.00	2,858	0	12,697	Feb 03 04:24 PM
LILLY ENDOWMENT INC	10% Owner	Jan 07 '26	Sale	1103.48	292,148	322,380,730	91,896,978	Jan 08 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jan 05 '26	Sale	1085.01	1,390	1,508,165	92,189,126	Jan 06 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Dec 29 '25	Sale	1085.04	3,593	3,898,531	92,190,516	Dec 30 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Dec 24 '25	Sale	1085.17	2,629	2,852,920	92,194,109	Dec 29 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Dec 23 '25	Sale	1085.04	240	260,409	92,196,738	Dec 29 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Dec 23 '25	Proposed Sale	1076.48	300,000	322,944,000		Dec 23 12:52 PM
LILLY ENDOWMENT INC	10% Owner	Nov 25 '25	Sale	1109.30	15,632	17,340,625	92,196,978	Nov 26 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 25 '25	Sale	1095.35	147,061	161,082,640	92,212,610	Nov 26 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 24 '25	Sale	1068.52	142,307	152,058,091	92,359,671	Nov 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 21 '25	Sale	1058.66	105,326	111,504,098	92,501,978	Nov 24 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 24 '25	Proposed Sale	1059.70	305,000	323,208,500		Nov 24 03:01 PM
LILLY ENDOWMENT INC	10% Owner	Nov 20 '25	Sale	1051.66	37,148	39,067,117	92,607,304	Nov 21 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 19 '25	Sale	1051.17	167,526	176,098,702	92,644,452	Nov 20 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 18 '25	Sale	1034.78	60,213	62,306,969	92,811,978	Nov 19 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 19 '25	Proposed Sale	1030.05	310,000	319,315,500		Nov 19 03:05 PM
LILLY ENDOWMENT INC	10% Owner	Nov 17 '25	Sale	1030.68	9,886	10,189,269	92,872,191	Nov 18 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 14 '25	Sale	1030.87	178,295	183,799,044	92,882,077	Nov 17 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 13 '25	Sale	1030.26	46,606	48,016,098	93,060,372	Nov 14 04:00 PM
Zakrowski Donald A	SVP, Finance, & CAO	Nov 13 '25	Sale	1010.50	1,000	1,010,500	2,840	Nov 13 04:14 PM
LILLY ENDOWMENT INC	10% Owner	Nov 12 '25	Sale	1011.18	305,000	308,411,204	93,106,978	Nov 13 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 13 '25	Proposed Sale	1017.78	295,000	300,245,100		Nov 13 03:02 PM
LILLY ENDOWMENT INC	10% Owner	Nov 11 '25	Sale	986.64	283,131	279,347,680	93,411,978	Nov 12 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 10 '25	Sale	972.52	16,869	16,405,396	93,695,109	Nov 12 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 12 '25	Proposed Sale	988.62	305,000	301,529,100		Nov 12 03:15 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 10 '25	Proposed Sale	924.37	300,000	277,311,000		Nov 10 03:11 PM
LILLY ENDOWMENT INC	10% Owner	Nov 05 '25	Sale	951.56	40,432	38,473,442	93,711,978	Nov 06 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 05 '25	Sale	933.26	179,042	167,092,104	93,752,410	Nov 06 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 04 '25	Sale	910.72	526	479,038	93,931,452	Nov 05 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 03 '25	Sale	888.83	300,000	266,648,921	93,931,978	Nov 04 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 04 '25	Proposed Sale	896.53	220,000	197,236,600		Nov 04 03:05 PM
LILLY ENDOWMENT INC	10% Owner	Oct 31 '25	Sale	863.35	301,342	260,165,031	94,231,978	Nov 03 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 03 '25	Proposed Sale	862.86	300,000	258,858,000		Nov 03 03:06 PM
LILLY ENDOWMENT INC	10% Owner	Oct 10 '25	Sale	863.24	3,658	3,157,722	94,533,320	Oct 14 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 09 '25	Sale	852.49	10,602	9,038,055	94,536,978	Oct 10 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 10 '25	Proposed Sale	855.35	305,000	260,881,750		Oct 10 02:57 PM
LILLY ENDOWMENT INC	10% Owner	Oct 08 '25	Sale	850.27	101,420	86,234,874	94,547,580	Oct 09 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 07 '25	Sale	848.01	26,795	22,722,401	94,649,000	Oct 08 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 06 '25	Sale	850.22	161,183	137,041,657	94,675,795	Oct 07 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 03 '25	Sale	837.93	192,404	161,220,401	94,836,978	Oct 06 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 06 '25	Proposed Sale	839.87	300,000	251,961,000		Oct 06 03:35 PM
LILLY ENDOWMENT INC	10% Owner	Oct 02 '25	Sale	821.55	112,596	92,503,361	95,029,382	Oct 03 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 01 '25	Sale	821.47	215,822	177,290,448	95,141,978	Oct 02 04:56 PM
LILLY ENDOWMENT INC	10% Owner	Oct 01 '25	Sale	794.15	135,193	107,363,016	95,357,800	Oct 02 04:55 PM
LILLY ENDOWMENT INC	10% Owner	Oct 02 '25	Proposed Sale	825.42	305,000	251,753,100		Oct 02 03:20 PM
LILLY ENDOWMENT INC	10% Owner	Oct 01 '25	Proposed Sale	763.00	295,000	225,085,000		Oct 01 04:08 PM
LILLY ENDOWMENT INC	10% Owner	Sep 30 '25	Sale	763.39	113,694	86,793,274	95,492,993	Oct 01 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Sep 19 '25	Sale	763.10	23,665	18,058,643	95,606,687	Sep 22 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Sep 18 '25	Sale	764.65	106,626	81,531,959	95,630,352	Sep 19 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Sep 18 '25	Proposed Sale	760.13	300,000	228,039,000		Sep 18 03:04 PM
DONALD ZAKROWSKI	Officer	Aug 28 '25	Proposed Sale	734.17	2,000	1,468,340		Aug 28 04:19 PM
Zakrowski Donald A	SVP, Finance, & CAO	Aug 28 '25	Sale	734.93	1,000	734,930	3,840	Aug 28 04:14 PM
Montarce Lucas	EVP & CFO	Aug 15 '25	Buy	691.79	715	494,627	14,685	Aug 15 04:13 PM
Alvarez Ralph	Director	Aug 13 '25	Buy	660.25	758	500,473	758	Aug 14 04:12 PM
Van Naarden Jacob	EVP & Pres., Lilly Oncology	Aug 13 '25	Buy	647.36	1,000	647,360	20,562	Aug 13 04:15 PM
Ricks David A	President, Chair, and CEO	Aug 12 '25	Buy	644.77	1,632	1,052,263	546,601	Aug 12 04:23 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Aug 12 '25	Buy	634.40	1,000	634,405	137,660	Aug 12 04:20 PM
Sulzberger Gabrielle	Director	Aug 12 '25	Buy	641.18	117	75,018	2,703	Aug 12 04:19 PM
Fyrwald J Erik	Director	Aug 12 '25	Buy	642.33	1,565	1,005,242	74,578	Aug 12 04:17 PM
Yuffa Ilya	EVP&Pres, LLY USA&Global Capab	Aug 11 '25	Sale	627.01	1,250	783,762	26,260	Aug 12 04:16 PM
JACKSON JAMERE	Director	Aug 08 '25	Buy	639.56	200	127,913	9,402	Aug 08 04:20 PM
Seymour Melissa	EVP, Global Quality	Aug 01 '25	Option Exercise	0.00	952	0	952	Aug 04 04:16 PM
LILLY ENDOWMENT INC	10% Owner	Jul 24 '25	Sale	805.07	280,000	225,419,259	95,736,978	Jul 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 24 '25	Proposed Sale	798.89	280,000	223,689,200		Jul 24 03:01 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LLY

Lilly(Eli) & Co

Upgrade your Finviz experience